Chordia Therapeutics Inc.

Direct answer

Chordia Therapeutics Inc. is publicly traded on JPX under the ticker 190A.T.

Chordia Therapeutics specializes in oncology, with its efforts spanning the entire drug discovery and development pipeline, from initial exploratory research through to Proof of Concept (POC) validation. To optimize future business growth and enhance corporate value, we are establishing a robust strategic framework that will guide decisions on approaches such as out-licensing, co-development partnerships, and joint...

Can you invest in Chordia Therapeutics Inc.?

Yes. Chordia Therapeutics Inc. is publicly traded on JPX under the ticker 190A.T.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Chordia Therapeutics Inc.

Detailed equity research is provided by MarketSnap.